Nicole Martin
Family · Columbus Grove, OHNPI 1013662840
Payments from drug & device makers
Across 112 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$335
- AstraZeneca$298
- Lilly USA, LLC$280
- AbbVie$252
- Otsuka America Pharmaceutical, Inc.$170
- Axsome Therapeutics, Inc.$145
- plus $589 from 16 others
What the payments were for
- Food & beverage$2,069100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $335 |
| AstraZeneca | 14 | $298 |
| Lilly USA, LLC | 14 | $280 |
| AbbVie | 18 | $252 |
| Otsuka America Pharmaceutical, Inc. | 9 | $170 |
| Axsome Therapeutics, Inc. | 4 | $145 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $87 |
| Abbott | 4 | $76 |
| Boston Scientific | 2 | $62 |
| Novartis | 2 | $33 |
| Viatris Specialty LLC | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Mylan Specialty L.p. | 1 | $24 |
| Pfizer | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $18 |
| GSK | 1 | $18 |
| Bayer | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
How this compares
$2,069 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus Grove
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.